US Stock MarketDetailed Quotes

LPCN Lipocine

Watchlist
  • 4.7600
  • -0.8300-14.85%
Close Nov 8 16:00 ET
  • 4.7600
  • 0.00000.00%
Post 20:01 ET
25.46MMarket Cap-6346P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Comments

    Jaguar8
    Jaguar8
    Oct 31 07:23
    NEWS
    $Lipocine (LPCN.US)$
    Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea
    Lipocine Inc. (NASDAQ: LPCN) has entered into a license, development and supply agreement with SPC Korea for exclusive marketing rights of TLANDO® in South Korea. The agreement includes an upfront payment, potential regulatory and sales milestone payments, royalties on net commercial sales, and a supply price arrangement. SPC Korea will be responsible for obtaining...
    Trytosaveabit
    Trytosaveabit
    Oct 10 05:13
    New 8K
    $Lipocine (LPCN.US)$ Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results
    ● Quantitative Electroencephalogram (qEEG) in healthy subjects administered single doses of oral brexanolone, a neuroactive steroid (NAS), confirmed GABAA modulation
    ● Rapid and durable CNS target engagement confirms effective oral delivery of bioidentical brexanolone
    ● Promising results support continued development of oral brexanolone for the treatment of neuropsychiatric disorders

    SALT LAKE CI...
    Jaguar8
    Jaguar8
    Oct 8 07:04
    NEWS
    $Lipocine (LPCN.US)$
    Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries
    Lipocine Inc. (NASDAQ: LPCN) has announced an exclusive supply and distribution agreement with Pharmalink to commercialize TLANDO®, its oral testosterone replacement therapy, in the Gulf Cooperation Council (GCC) countries. The agreement covers Saudi Arabia, Kuwait, the United Arab Emirates, Qatar, Bahrain, and Oman.
    Under the term...
    Trytosaveabit
    Trytosaveabit
    Oct 8 07:01
    News
    $Lipocine (LPCN.US)$ Reuters just
    Lipocine Announces Supply and Distribution Agreement With Pharmalink to Commercialize Tlando® in the Gulf Cooperation Council (GCC) Countries
    1
    Jaguar8
    Jaguar8
    Sep 5 07:02
    NEES
    $Lipocine (LPCN.US)$
    Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek®
    Study evaluated LPCN 2401 in participants with obesity (BMI ≥30) and participants with BMI ≥27 with at least one weight-related comorbidity
    SALT LAKE CITY, Sept. 5, 2024 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that a poster featuring Phase 2 da...
Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data